FAF
BIO icon

Första AP-fonden’s Bio-Rad Laboratories Class A BIO Stock Holding History

Första AP-fonden’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,500
Closed -$2.23M – 586
2022
Q2 		$2.23M Buy
+4,500
New +$2.34M 0.03% 500
2021
Q4 		– Sell
-3,400
Closed -$2.54M – 563
2021
Q3 		$2.54M Buy
+3,400
New +$2.55M 0.03% 486
2021
Q1 		– Sell
-2,600
Closed -$1.52M – 531
2020
Q4 		$1.52M Buy
+2,600
New +$1.48M 0.02% 484
2020
Q3 		– Sell
-2,900
Closed -$1.31M – 524
2020
Q2 		$1.31M Buy
2,900
+2,300
+383% +$1.01M 0.03% 467
2020
Q1 		$210K Buy
+600
New +$221K 0.01% 469

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Första AP-fonden's BIO Position: Q3 2022 in Review

Första AP-fonden sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2022, closing a stake of 4,500 shares — an estimated $2.23M sold.

Första AP-fonden first reported a position in BIO in Q1 2020 and held it in 5 quarters. The position peaked at $2.54M in Q3 2021. 484 funds tracked by Wall St. Rank hold BIO as of Q3 2022.

  • Första AP-fonden reported no remaining Bio-Rad Laboratories Class A position as of Q3 2022 after selling out during the quarter.
  • Första AP-fonden sold 4,500 Bio-Rad Laboratories Class A shares in Q3 2022, an estimated $2.23M.
  • Första AP-fonden first reported a position in Bio-Rad Laboratories Class A in Q1 2020 and held it in 5 quarters.
  • Första AP-fonden's Bio-Rad Laboratories Class A position peaked at $2.54M in Q3 2021.
  • 484 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2022.

Based on Första AP-fonden's 13F filing for Q3 2022, filed 17 Oct 2022.